Mon, Mar 31, 7:58 PM (20 days ago)
### Summary of BioLargo, Inc. (BLGO) Annual Report (2024) **Financial Performance:** - **Revenue:** $17,779,000 (2024) vs. $12,230,000 (2023) - **Net Loss:** $4,347,000 (2024) vs. $4,648,000 (2023) - **Operating Expenses:** $12,184,000 (2024) vs. $10,734,000 (2023) - **Research & Development:** $2,882,000 (2024) vs. $2,282,000 (2023) - **Cash Used in Operations:** $3,206,000 (2024) **Strategic Overview:** - **Business Segments:** ONM Environmental, BLEST, Clyra Medical, BETI, BEST, BioLargo Canada, and corporate operations. - **Key Products:** CupriDyne Clean, AEC (PFAS treatment), AOS (water treatment), Cellinity™ battery, Bioclynse (wound irrigation). **Future Outlook:** - **Growth Opportunities:** Expansion in odor control, water treatment, battery technology, and medical products. - **Challenges:** Market adoption, regulatory approvals, and competition. **Risk Factors:** - **Financial Condition:** Recurring losses, negative cash flow, and reliance on financing. - **Market Risks:** Customer concentration, supply chain challenges, and regulatory hurdles. - **Operational Risks:** Dependence on key personnel, intellectual property risks, and cybersecurity threats. **Financial Condition:** - **Cash and Cash Equivalents:** $3,548,000 (2024) - **Debt Obligations:** $1,079,000 (2024) - **Working Capital:** $4,489,000 (2024) **Market Position Changes:** - **Revenue Growth:** 45% increase in 2024, driven by product sales and engineering services. - **Customer Concentration:** One customer accounted for 77% of total revenue in 2024. **Key Financial Metrics:** - **Earnings Per Share (EPS):** -$0.01 (2024) - **Weighted Average Shares Outstanding:** 298,122,239 (2024) **Operating Segments:** - **ONM Environmental:** $15,597,000 revenue (2024), $5,920,000 operating income. - **BLEST:** $2,182,000 revenue (2024), $1,453,000 operating loss. - **Clyra Medical:** $3,324,000 operating loss (2024). - **BETI:** $642,000 operating loss (2024). - **BEST:** $273,000 operating loss (2024). - **BioLargo Canada:** $504,000 operating loss (2024). **Subsequent Events:** - **Clyra Medical:** Additional stock sales and promissory notes issued post-2024. **Note:** All amounts are in thousands ($000s).